Brooks Laboratories Limited (NSE:BROOKS)

Oncternal Therapeutics Revenue

Brooks Laboratories had revenue of 257.29M INR in the quarter ending June 30, 2025, with 43.47% growth. This brings the company's revenue in the last twelve months to 902.84M, up 10.48% year-over-year. In the fiscal year ending March 31, 2025, Brooks Laboratories had annual revenue of 825.57M with 3.86% growth.

• Revenue (ttm): 902.84M
• Revenue Growth: +10.48%
• P/S Ratio: 5.15
• Revenue / Employee: 3.08M
• Employees: 293
• Market Cap: 4.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	825.57M	30.71M	3.86%
Mar 31, 2024	794.86M	162.82M	25.76%
Mar 31, 2023	632.05M	-279.80M	-30.69%
Mar 31, 2022	911.85M	139.38M	18.04%
Mar 31, 2021	772.47M	75.58M	10.85%